The Brazilian Health Regulatory Agency (Anvisa) grants emergency use authorization requests for the vaccines developed by Sinovac and Oxford-AstraZeneca. (G1) COVID-19 pandemic in Brazil, COVID-19 vaccineCOVID-19 pandemic link embed save